Pre-order Enquiry
Request Free Sample
Global Fibrate Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18698423 | Publishing Date : 06-Jul-2021 | No. of pages : 119
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Fibrate Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Fibrate Drugs1.1 Fibrate Drugs Market Overview
1.1.1 Fibrate Drugs Product Scope
1.1.2 Fibrate Drugs Market Status and Outlook
1.2 Global Fibrate Drugs Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Fibrate Drugs Market Size by Region (2016-2027)
1.4 Global Fibrate Drugs Historic Market Size by Region (2016-2021)
1.5 Global Fibrate Drugs Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Fibrate Drugs Market Size (2016-2027)
1.6.1 North America Fibrate Drugs Market Size (2016-2027)
1.6.2 Europe Fibrate Drugs Market Size (2016-2027)
1.6.3 Asia-Pacific Fibrate Drugs Market Size (2016-2027)
1.6.4 Latin America Fibrate Drugs Market Size (2016-2027)
1.6.5 Middle East & Africa Fibrate Drugs Market Size (2016-2027)
2 Fibrate Drugs Market Overview by Type
2.1 Global Fibrate Drugs Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Fibrate Drugs Historic Market Size by Type (2016-2021)
2.3 Global Fibrate Drugs Forecasted Market Size by Type (2022-2027)
2.4 Lofibrate
2.5 Fenofibrates
2.6 Fenofibric Acids
2.7 Gemfibrozil
3 Fibrate Drugs Market Overview by Application
3.1 Global Fibrate Drugs Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Fibrate Drugs Historic Market Size by Application (2016-2021)
3.3 Global Fibrate Drugs Forecasted Market Size by Application (2022-2027)
3.4 Hospitals Pharmacies
3.5 Retail Pharmacies
3.6 Online Pharmacies
4 Fibrate Drugs Competition Analysis by Players
4.1 Global Fibrate Drugs Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fibrate Drugs as of 2020)
4.3 Date of Key Players Enter into Fibrate Drugs Market
4.4 Global Top Players Fibrate Drugs Headquarters and Area Served
4.5 Key Players Fibrate Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Fibrate Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Teva Pharmaceutical Industries
5.1.1 Teva Pharmaceutical Industries Profile
5.1.2 Teva Pharmaceutical Industries Main Business
5.1.3 Teva Pharmaceutical Industries Fibrate Drugs Products, Services and Solutions
5.1.4 Teva Pharmaceutical Industries Fibrate Drugs Revenue (US$ Million) & (2016-2021)
5.1.5 Teva Pharmaceutical Industries Recent Developments
5.2 Pfizer, Inc.
5.2.1 Pfizer, Inc. Profile
5.2.2 Pfizer, Inc. Main Business
5.2.3 Pfizer, Inc. Fibrate Drugs Products, Services and Solutions
5.2.4 Pfizer, Inc. Fibrate Drugs Revenue (US$ Million) & (2016-2021)
5.2.5 Pfizer, Inc. Recent Developments
5.3 Mylan N.V.
5.5.1 Mylan N.V. Profile
5.3.2 Mylan N.V. Main Business
5.3.3 Mylan N.V. Fibrate Drugs Products, Services and Solutions
5.3.4 Mylan N.V. Fibrate Drugs Revenue (US$ Million) & (2016-2021)
5.3.5 Sanofi SA Recent Developments
5.4 Sanofi SA
5.4.1 Sanofi SA Profile
5.4.2 Sanofi SA Main Business
5.4.3 Sanofi SA Fibrate Drugs Products, Services and Solutions
5.4.4 Sanofi SA Fibrate Drugs Revenue (US$ Million) & (2016-2021)
5.4.5 Sanofi SA Recent Developments
5.5 Novartis AG
5.5.1 Novartis AG Profile
5.5.2 Novartis AG Main Business
5.5.3 Novartis AG Fibrate Drugs Products, Services and Solutions
5.5.4 Novartis AG Fibrate Drugs Revenue (US$ Million) & (2016-2021)
5.5.5 Novartis AG Recent Developments
5.6 GlaxoSmithKline plc
5.6.1 GlaxoSmithKline plc Profile
5.6.2 GlaxoSmithKline plc Main Business
5.6.3 GlaxoSmithKline plc Fibrate Drugs Products, Services and Solutions
5.6.4 GlaxoSmithKline plc Fibrate Drugs Revenue (US$ Million) & (2016-2021)
5.6.5 GlaxoSmithKline plc Recent Developments
5.7 Sun Pharmaceutical Industries, Inc.
5.7.1 Sun Pharmaceutical Industries, Inc. Profile
5.7.2 Sun Pharmaceutical Industries, Inc. Main Business
5.7.3 Sun Pharmaceutical Industries, Inc. Fibrate Drugs Products, Services and Solutions
5.7.4 Sun Pharmaceutical Industries, Inc. Fibrate Drugs Revenue (US$ Million) & (2016-2021)
5.7.5 Sun Pharmaceutical Industries, Inc. Recent Developments
5.8 Macleods Pharmaceuticals Limited
5.8.1 Macleods Pharmaceuticals Limited Profile
5.8.2 Macleods Pharmaceuticals Limited Main Business
5.8.3 Macleods Pharmaceuticals Limited Fibrate Drugs Products, Services and Solutions
5.8.4 Macleods Pharmaceuticals Limited Fibrate Drugs Revenue (US$ Million) & (2016-2021)
5.8.5 Macleods Pharmaceuticals Limited Recent Developments
5.9 Aurobindo Pharma
5.9.1 Aurobindo Pharma Profile
5.9.2 Aurobindo Pharma Main Business
5.9.3 Aurobindo Pharma Fibrate Drugs Products, Services and Solutions
5.9.4 Aurobindo Pharma Fibrate Drugs Revenue (US$ Million) & (2016-2021)
5.9.5 Aurobindo Pharma Recent Developments
5.10 Abbott
5.10.1 Abbott Profile
5.10.2 Abbott Main Business
5.10.3 Abbott Fibrate Drugs Products, Services and Solutions
5.10.4 Abbott Fibrate Drugs Revenue (US$ Million) & (2016-2021)
5.10.5 Abbott Recent Developments
6 North America
6.1 North America Fibrate Drugs Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Fibrate Drugs Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Fibrate Drugs Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Fibrate Drugs Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Fibrate Drugs Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Fibrate Drugs Market Dynamics
11.1 Fibrate Drugs Industry Trends
11.2 Fibrate Drugs Market Drivers
11.3 Fibrate Drugs Market Challenges
11.4 Fibrate Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Fibrate Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Fibrate Drugs Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global Fibrate Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global Fibrate Drugs Market Size Share by Region (2016-2021)
Table 4. Global Fibrate Drugs Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global Fibrate Drugs Forecasted Market Size Share by Region (2022-2027)
Table 6. Global Fibrate Drugs Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global Fibrate Drugs Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global Fibrate Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Fibrate Drugs Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global Fibrate Drugs Revenue Market Share by Type (2022-2027)
Table 11. Global Fibrate Drugs Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global Fibrate Drugs Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global Fibrate Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Fibrate Drugs Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global Fibrate Drugs Revenue Market Share by Application (2022-2027)
Table 16. Global Fibrate Drugs Revenue (US$ Million) by Players (2016-2021)
Table 17. Global Fibrate Drugs Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fibrate Drugs as of 2020)
Table 19. Date of Key Manufacturers Enter into Fibrate Drugs Market
Table 20. Global Fibrate Drugs Top Players Headquarters and Area Served
Table 21. Fibrate Drugs Product Solution and Service
Table 22. Global Fibrate Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Teva Pharmaceutical Industries Basic Information List
Table 25. Teva Pharmaceutical Industries Description and Business Overview
Table 26. Teva Pharmaceutical Industries Fibrate Drugs Products, Services and Solutions
Table 27. Revenue (US$ Million) in Fibrate Drugs Business of Teva Pharmaceutical Industries (2016-2021)
Table 28. Teva Pharmaceutical Industries Recent Developments
Table 29. Pfizer, Inc. Basic Information List
Table 30. Pfizer, Inc. Description and Business Overview
Table 31. Pfizer, Inc. Fibrate Drugs Products, Services and Solutions
Table 32. Revenue (US$ Million) in Fibrate Drugs Business of Pfizer, Inc. (2016-2021)
Table 33. Pfizer, Inc. Recent Developments
Table 34. Mylan N.V. Basic Information List
Table 35. Mylan N.V. Description and Business Overview
Table 36. Mylan N.V. Fibrate Drugs Products, Services and Solutions
Table 37. Revenue (US$ Million) in Fibrate Drugs Business of Mylan N.V. (2016-2021)
Table 38. Mylan N.V. Recent Developments
Table 39. Sanofi SA Basic Information List
Table 40. Sanofi SA Description and Business Overview
Table 41. Sanofi SA Fibrate Drugs Products, Services and Solutions
Table 42. Revenue (US$ Million) in Fibrate Drugs Business of Sanofi SA (2016-2021)
Table 43. Sanofi SA Recent Developments
Table 44. Novartis AG Basic Information List
Table 45. Novartis AG Description and Business Overview
Table 46. Novartis AG Fibrate Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Fibrate Drugs Business of Novartis AG (2016-2021)
Table 48. Novartis AG Recent Developments
Table 49. GlaxoSmithKline plc Basic Information List
Table 50. GlaxoSmithKline plc Description and Business Overview
Table 51. GlaxoSmithKline plc Fibrate Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Fibrate Drugs Business of GlaxoSmithKline plc (2016-2021)
Table 53. GlaxoSmithKline plc Recent Developments
Table 54. Sun Pharmaceutical Industries, Inc. Basic Information List
Table 55. Sun Pharmaceutical Industries, Inc. Description and Business Overview
Table 56. Sun Pharmaceutical Industries, Inc. Fibrate Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Fibrate Drugs Business of Sun Pharmaceutical Industries, Inc. (2016-2021)
Table 58. Sun Pharmaceutical Industries, Inc. Recent Developments
Table 59. Macleods Pharmaceuticals Limited Basic Information List
Table 60. Macleods Pharmaceuticals Limited Description and Business Overview
Table 61. Macleods Pharmaceuticals Limited Fibrate Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Fibrate Drugs Business of Macleods Pharmaceuticals Limited (2016-2021)
Table 63. Macleods Pharmaceuticals Limited Recent Developments
Table 64. Aurobindo Pharma Basic Information List
Table 65. Aurobindo Pharma Description and Business Overview
Table 66. Aurobindo Pharma Fibrate Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Fibrate Drugs Business of Aurobindo Pharma (2016-2021)
Table 68. Aurobindo Pharma Recent Developments
Table 69. Abbott Basic Information List
Table 70. Abbott Description and Business Overview
Table 71. Abbott Fibrate Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Fibrate Drugs Business of Abbott (2016-2021)
Table 73. Abbott Recent Developments
Table 74. North America Fibrate Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 75. North America Fibrate Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 76. Europe Fibrate Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 77. Europe Fibrate Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 78. Asia-Pacific Fibrate Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 79. Asia-Pacific Fibrate Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 80. Asia-Pacific Fibrate Drugs Market Share by Region (2016-2021)
Table 81. Asia-Pacific Fibrate Drugs Market Share by Region (2022-2027)
Table 82. Latin America Fibrate Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 83. Latin America Fibrate Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 84. Middle East & Africa Fibrate Drugs Market Size by Players (2016-2021) & (US$ Million)
Table 85. Middle East & Africa Fibrate Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 86. Fibrate Drugs Market Trends
Table 87. Fibrate Drugs Market Drivers
Table 88. Fibrate Drugs Market Challenges
Table 89. Fibrate Drugs Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fibrate Drugs Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global Fibrate Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global Fibrate Drugs Market Share by Regions: 2021 VS 2027
Figure 4. Global Fibrate Drugs Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America Fibrate Drugs Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe Fibrate Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific Fibrate Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America Fibrate Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa Fibrate Drugs Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global Fibrate Drugs Market Size Share by Type in 2021 & 2027
Figure 11. Lofibrate Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Fenofibrates Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Fenofibric Acids Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Gemfibrozil Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Global Fibrate Drugs Market Size Share by Application in 2021 & 2027
Figure 16. Hospitals Pharmacies Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Retail Pharmacies Market Size (US$ Million) YoY Growth (2016-2027)
Figure 18. Online Pharmacies Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Fibrate Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Top 5 and Top 10 Players Fibrate Drugs Market Share in 2020
Figure 21. North America Fibrate Drugs Market Share by Country (2016-2027)
Figure 22. United States Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 23. Canada Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 24. Germany Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 25. France Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 26. U.K. Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 27. Italy Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 28. Russia Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 29. Nordic Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 30. Rest of Europe Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 31. Asia-Pacific Fibrate Drugs Market Share by Region (2016-2027)
Figure 32. China Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 33. Japan Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 34. South Korea Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 35. Southeast Asia Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 36. India Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 37. Australia Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 38. Rest of Asia-Pacific Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 39. Latin America Fibrate Drugs Market Share by Country (2016-2027)
Figure 40. Mexico Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 41. Brazil Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 42. Rest of Latin America Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 43. Middle East & Africa Fibrate Drugs Market Share by Country (2016-2027)
Figure 44. Turkey Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 45. Saudi Arabia Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 46. UAE Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 47. Rest of Middle East & Africa Fibrate Drugs Market Size (2016-2027) & (US$ Million)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Keyplayers in Global Fibrate Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
Teva Pharmaceutical IndustriesPfizer, Inc.
Mylan N.V.
Sanofi SA
Novartis AG
GlaxoSmithKline plc
Sun Pharmaceutical Industries, Inc.
Macleods Pharmaceuticals Limited
Aurobindo Pharma
Abbott
